Unlocking Value: Exploring Tonix Pharmaceuticals and Other Low P/B Ratio Stocks
In a market crowded with flashy headlines and speculative ventures, the allure of undervalued stocks remains steadfast. Stocks such as Tonix Pharmaceuticals (NASDAQ: TNXP) and others with low price-to-book (P/B) ratios offer investors a promising avenue. Let’s delve into the fundamentals behind these opportunities and the potential they hold for investors. Tonix Pharmaceuticals Tonix Pharmaceuticals […]
Tonix Pharmaceutical Holding Corp. (TNXP) Stock Prices Lack Volatility Following OyaGen Collaboration
TonixPharaceuticals Holding Corp. (TNXP) stock prices are up 0.97% as of market close on April 23rd, 2021, bringing the price per share up to USD$1.04. Collaboration with OyaGen April 19th, 2021 saw TNXP announce their exclusive worldwide licensing agreement with OyaGen for the development of TNX-3500. The experimental COVID-19 antiviral drug is a highly promising […]